BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma

BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma

Abstract Background The intensive interplay between aberrant epigenetic events and metabolic remodeling represents one of the hallmarks of tumors, including colon cancer. The functions of Bromodomain Containing Protein BRD‐9 in colon cancer remains indefinite. We aimed to identify the biological rol...

Full description

Bibliographic Details
Main Authors: Qunshan Zhu, Xiang Gu, Wei Wei, Zheng Wu, Fengqin Gong, Xiaoqiang Dong
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
BRD9
colon cancer
epigenetic modification
glycolysis
I‐BRD9
Online Access:https://doi.org/10.1002/cam4.4954

Similar Items

Similar Items